Skip to content

A retrospective observational study on the method of determining the extent of lymph node dissection using 3D-CTA in splenic flexure colon carcinoma

A retrospective observational study on the method of determining the extent of lymph node dissection using 3D-CTA in splenic flexure colon carcinoma - A retrospective observational study on the method of determining the extent of lymph node dissection using 3D-CTA in splenic flexure colon carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047600
Enrollment
100
Registered
2022-04-27
Start date
2010-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Splenic flexure colon cancer

Interventions

None listed

Sponsors

Fujisawa City Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Splenic flexure colon cancer Laparoscopic surgery Preoperative 3D-CTA

Exclusion criteria

Exclusion criteria: Emergency surgery Palliative surgery Laparotomy Cases in which preoperative 3D-CTA could not be performed due to contrast allergy or renal dysfunction Active multiple cancers

Design outcomes

Primary

MeasureTime frame
5 year overall survival rate

Countries

Japan

Contacts

Public ContactKoichi Mori

Fujisawa city hospital Department of surgery

junkawashima0622@gmail.com0466253111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026